Cornerstone Investment Partners’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,265
Closed -$186K 242
2024
Q4
$186K Buy
11,265
+15
+0.1% +$233 0.01% 219
2024
Q3
$166K Buy
11,250
+340
+3% +$5.32K 0.01% 199
2024
Q2
$151K Buy
+10,910
New +$155K 0.01% 196
2020
Q1
Sell
-10,081
Closed -$295K 203
2019
Q4
$295K Buy
+10,081
New +$240K 0.01% 96

Other funds holding NEO

Cornerstone Investment Partners's NEO Position: Q1 2025 in Review

Cornerstone Investment Partners sold out of NeoGenomics (NEO) in Q1 2025, closing a stake of 11,265 shares — an estimated $186K sold.

Cornerstone Investment Partners first reported a position in NEO in Q4 2019 and held it in 4 quarters. The position peaked at $295K in Q4 2019. 256 funds tracked by Wall St. Rank hold NEO as of Q1 2025.

  • Cornerstone Investment Partners reported no remaining NeoGenomics position as of Q1 2025 after selling out during the quarter.
  • Cornerstone Investment Partners sold 11,265 NeoGenomics shares in Q1 2025, an estimated $186K.
  • Cornerstone Investment Partners first reported a position in NeoGenomics in Q4 2019 and held it in 4 quarters.
  • Cornerstone Investment Partners's NeoGenomics position peaked at $295K in Q4 2019.
  • 256 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2025.

Based on Cornerstone Investment Partners's 13F filing for Q1 2025, filed 30 Apr 2025.